Novartis Times and Sales

Novartis Aktie VALOR 1200526 / ISIN CH0012005267

84.06

CHF

-0.83

CHF

-0.98%

14:33:26

SWX

Kaufen Verkaufen

oder

Trading

Kurse + Charts + Realtime		News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen
			Ausblick

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Strukturierte Produkte

Aktion

Portfolio

Watchlist

Zeit	Kurs	Umsatz (Stk)	Umsatz grafisch
14:34:31	84.050	24
14:34:31	84.060	183
14:34:31	84.060	39
14:34:31	84.060	129
14:34:31	84.060	12
14:34:31	84.060	300
14:33:26	84.060	17
14:33:25	84.060	91
14:33:25	84.070	64
14:33:25	84.070	12
14:33:25	84.070	133
14:33:13	84.080	19
14:33:07	84.070	104
14:32:11	84.070	113
14:32:11	84.070	184
14:32:11	84.070	43
14:32:11	84.070	160
14:32:09	84.080	12
14:32:09	84.080	21
14:31:45	84.080	14
14:31:31	84.090	9
14:31:11	84.090	7
14:31:11	84.090	99
14:31:11	84.100	140
14:31:11	84.100	100
14:30:47	84.070	146
14:30:35	84.070	66
14:30:35	84.070	38
14:30:35	84.070	148
14:30:01	84.060	35
14:30:01	84.060	100
14:29:56	84.070	132
14:28:52	84.060	18
14:28:51	84.070	93
14:28:50	84.070	133
Kursrückgang	Kursanstieg		keine Kursänderung
(Balkenlänge beschreibt das Umsatzvolumen)

12:24		Verluste in Europa: STOXX 50 mittags schwächer
12:24		Schwacher Wochentag in Zürich: SMI am Donnerstagmittag im Minus
09:26		Minuszeichen in Europa: STOXX 50 notiert zum Handelsstart im Minus
09:26		Schwacher Wochentag in Zürich: SMI fällt zum Start
06.12.23		Pluszeichen in Zürich: SLI verbucht letztendlich Zuschläge
06.12.23		Aufschläge in Zürich: SMI zum Ende des Mittwochshandels im Aufwind
06.12.23		Zuversicht in Europa: STOXX 50 verbucht letztendlich Zuschläge
06.12.23		Novartis-Aktie dreht ins Minus: Novartis erhält von FDA Zulassung für Mittel gegen seltene Blutkrankheit

05.12.23	Novartis Neutral
30.11.23	Novartis Buy
29.11.23	Novartis Underweight
28.11.23	Novartis Neutral
28.11.23	Novartis Buy

14:42		Apple at a $3 Trillion Market Cap: Buy, Sell, or Hold?
14:41		Fintech Trends In 2024: AI, BaaS, Payments, And Regulatory Scrutiny
14:40		Danish Union On Sympathy Strike Against Tesla Found To Have $58M Invested In EV Giant Via Pension Fund
14:34		Is AMD the Top AI Stock to Own After Its AI Event?
14:33		$1.7M Bet On Erasca? Check Out These 4 Penny Stocks Insiders Are Aggressively Buying
14:30		Should You Buy Eli Lilly Stock Now or Wait for a Dip?
14:26		Verleger fordern klare Regeln für den Umgang mit KI im Journalismus
14:25		Is Google’s Gemini really smarter than OpenAI's GPT-4? Community sleuths find out
14:19		This Latest News Could Spell Trouble for ChargePoint Stock Investors
14:18		: Braze price target increased to $65 from $53 at D.A. Davidson
14:16		How To Earn $500 A Month From Campbell Soup Stock Following Upbeat Earnings
14:16		: Shake Shack upgraded to strong buy from outperform at Raymond James
14:15		How Is The Market Feeling About Energy Transfer?
14:15		Looking Into General Mills's Recent Short Interest
14:15		Looking for the Next Big Thing? Add This AI Biotech to Your Watch List Right Now
14:10		Large-scale TIDES purification with MCSGP under GMP
14:07		: MGP Ingredients price target cut to $125 from $140 at Truist Securities
14:06		: Sir Jim Ratcliffe set to clinch Manchester United minority stake next week, reports say
14:04		Why Autonomous Technology Company Cyngn Shares Are Skyrocketing Today
14:03		Market Extra: Value stocks were poised for glory in 2023, then it all slipped away as AI euphoria took over. Here’s what to expect next.
14:01		Beat Inflation With These 3 High-Yielding Dividend Stocks In Defensive Sector From Wall Street's Most Accurate Analysts
14:01		Could This News Derail Palantir's Incredible Rally?
14:00		The Latest Analyst Ratings for Alcoa
14:00		5 Analysts Have This to Say About LCI Indus
14:00		What 16 Analyst Ratings Have To Say About FMC
14:00		The Latest Analyst Ratings for Biogen
14:00		Where Prudential Financial Stands With Analysts
14:00		Yes, There's an Ideal Temperature to Set Your Thermostat for Winter - CNET
14:00		iPhone Storage Saver Tip: Delete Identical Photos From iCloud Right Now - CNET
14:00		Expert Ratings for Bio-Techne
14:00		Celebrate This Holiday Season With Delicious and Healthy Baking Recipes
14:00		Best Banks for Customer Experience - CNET
13:59		Why Cerevel Therapeutics Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket
13:59		UBS landet «Touchdown» bei NFL-Profis
13:58		Furniture Company Hooker Furnishings Beats On Q3 Despite Housing Market Slowdown; Aligns Inventory Levels With Current Demand
13:56		Nach Signa-Untergang: René Benko wird von der Forbes-Milliardärsliste gestrichen
13:55		Earnings Results: Dollar General’s stock buoyed by earnings beat, but retailer is not happy with its performance
13:53		Mehr Druck durch neue Bewertung?: SAP will Belegschaft in "Bringer" und "Nicht-Bringer" unterteilen
13:51		René Benko wird von der Forbes-Milliardärsliste gestrichen
13:50		: Williams Cos. price target hiked to $43 from $41 at Mizuho Securities USA
13:48		: EyePoint Pharma price target raised by $10 to $30 at Mizuho Securities USA
13:47		: Vaxcyte initiated with buy rating and $69 target price at Mizuho Securities USA
13:46		: FMC downgraded to neutral from buy at Mizuho Securities USA
13:45		A Bull Market Is Coming: 1 Stock to Buy on the Dip and 1 to Avoid Like the Plague
13:43		BBC licence fee to rise by £10.50 to £169.50 in 2024, culture secretary says
13:42		Google Fires Biggest Salvo Against OpenAI With Gemini — And TikTok Parent Says 'More Powerful' Model Coming Anytime Now
13:42		: Ramaco Resources price target raised to $20 from $15 at Benchmark
13:41		Datadog To Rally Over 22%? Here Are 10 Top Analyst Forecasts For Thursday
13:41		: Sprinklr price target reduced by $1 to $15 at Stifel
13:40		: Semtech price target trimmed to $22 from $24 at Stifel

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Novartis Aktie VALOR 1200526 / ISIN CH0012005267

Novartis Times and Sales (SWX)

Eintrag hinzufügen Eintrag bearbeiten

Nachrichten zu Novartis AG

Analysen zu Novartis AG

Weitere Meldungen